Response to zolendronic acid in children with type III osteogenesis imperfecta - Panigrahi, Inusha; Das, Rashmi Ranjan; Sharda, Sheetal; Marwaha, Ram Kumar; Khandelwal, Niranjan (Journal of bone and mineral metabolism, 2010)
Keywords: Acids; Biological and medical sciences; Bisphosphonates; Bone density; Bone Density Conservation Agents; Bone Density Conservation Agents - therapeutic use; Bones; Bones, joints and connective tissue. Antiinflammatory agents; Child, Preschool; Children; DEXA; Diphosphonates; Diphosphonates - therapeutic use; Diseases of the osteoarticular system; drug therapy; Female; Humans; Imidazoles; Imidazoles - therapeutic use; Infant; Male; Malformations and congenital and or hereditary diseases involving bones. Joint deformations; Medical sciences; Medicine; Medicine & Public Health; Metabolic Diseases; Original Article; Orthopedics; Osteogenesis Imperfecta; Osteogenesis Imperfecta - diagnostic imaging; Osteogenesis Imperfecta - drug therapy; Osteoporosis; Osteoporosis. Osteomalacia. Paget disease; Pharmacology. Drug treatments; Radiography; therapeutic use; Zolendronic acid; Osteoporosis; Children; DEXA; Bisphosphonates; Zolendronic acid; Human; Antiosteoporotic; Diseases of the osteoarticular system; Rheumatology; Genetic disease; Antiosteoclastic agent; Osteogenesis imperfecta; Osteochondrodysplasia; Child